Mucosal expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor-α in Crohn's disease in deep remission under treatment with anti-TNFα antibodies.

MLA

Tursi, Antonio, et al. “Mucosal Expression of Basic Fibroblastic Growth Factor, Syndecan 1 and Tumour Necrosis Factor-α in Crohn’s Disease in Deep Remission under Treatment with Anti-TNFα Antibodies.” Journal of Gastrointestinal and Liver Diseases : JGLD, vol. 23, no. 3, Sept. 2014, pp. 261–65. EBSCOhost, https://doi.org/10.15403/jgld.2014.1121.233.we2.

APA

Tursi, A., Elisei, W., Principi, M., Inchingolo, C. D., Nenna, R., Picchio, M., Giorgio, F., Ierardi, E., & Brandimarte, G. (2014). Mucosal expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor-α in Crohn’s disease in deep remission under treatment with anti-TNFα antibodies. Journal of Gastrointestinal and Liver Diseases : JGLD, 23(3), 261–265. https://doi.org/10.15403/jgld.2014.1121.233.we2

Chicago

Tursi, Antonio, Walter Elisei, Mariabeatrice Principi, Cosimo Damiano Inchingolo, Rosanna Nenna, Marcello Picchio, Floriana Giorgio, Enzo Ierardi, and Giovanni Brandimarte. 2014. “Mucosal Expression of Basic Fibroblastic Growth Factor, Syndecan 1 and Tumour Necrosis Factor-α in Crohn’s Disease in Deep Remission under Treatment with Anti-TNFα Antibodies.” Journal of Gastrointestinal and Liver Diseases : JGLD 23 (3): 261–65. doi:10.15403/jgld.2014.1121.233.we2.